Skip to content

Effect of Bispectral Index Monitoring (BIS) on Body Movement of Outpatients Undergoing Gastroscopy

Effect of Bispectral Index Monitoring and Observer's Assessment Alert Sedation Scale (OAA/S) Guided Sedation on Body Movement of Outpatients Undergoing Gastroscopy: a Randomized Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05773807
Acronym
BIS
Enrollment
400
Registered
2023-03-17
Start date
2022-01-01
Completion date
2023-02-15
Last updated
2023-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastroscopy

Brief summary

Patients who meet the enrollment criteria were randomized 1:1 to either the BIS group or the OAA/S group. In the BIS group, the anesthesiologist set the target controlled infusion(TCI)parameters according to the patient's height, weight, gender and age. The initial plasma target concentration was set to 1.5 ug/ml, and the target concentration would be increased or decreased 0.5 ug/ml every two minutes to maintain the BIS value at 45-60. In the OAA/S group, the target concentration would be increased or decreased 0.5 ug/ml every two minutes to maintain the OAA/S value at 1 point.

Detailed description

Patients who meet the enrollment criteria were randomized 1:1 to either the BIS group or the OAA/S group. In the BIS group, the anesthesiologist set the target controlled infusion (TCI) parameters according to the patient's height, weight, gender and age. The initial plasma target concentration was set to 1.5 ug/ml, and the target concentration would be increased or decreased 0.5 ug/ml every two minutes to maintain the BIS value at 45-60. In the OAA/S group, the target concentration would be increased or decreased 0.5 ug/ml every two minutes to maintain the OAA/S value at 1 point. Body movement, the time of gastroscopy, endoscopist satisfaction scores to sedation, the propofol consumption during gastroscopy and the time to awake were be recorded. In addition, the event of the respiration and circulation suppression during the gastroscopy were recorded. Atropine 0.3 mg was injected intravenously if bradycardia occurred (heart rate \<50 beats/min), M-hydroxyamine 0.3 mg was injected intravenously if hypotension (mean arterial pressure\<65 mmHg), Ephedrine 3 mg was injected if bradycardia and hypotension occured. Patients would receive face mask-assisted ventilation if the Spo2 dropped below 90% or respiratory frequency was lower than 8 breaths/min during the gastroscopy.

Interventions

In the BIS group, the anesthesiologist set the target controlled infusion (TCI) parameters according to the patient's height, weight, gender and age. The initial plasma target concentration was set to 1.5ug/ml, and the target concentration would be increased or decreased 0.5ug/ ml every two minutes to maintain the BIS value at 45-60.

OTHERObserver's assessment alert Sedation

In the OAA/S group, the anesthesiologist set the TCI parameters according to the patient's height, weight, gender and age. The initial plasma target concentration was set to 1.5ug/ml, and the target concentration would be increased or decreased 0.5ug/ ml every two minutes maintain the OAA/S value at 1 point.

PROCEDUREGastroscopy

Gastroscopy would be performed when the BIS value was 45-60 or the OAA/S score was 1

DRUGPropofol

Propofol infusion was administered under the guidance of the BIS or OAA/S before the gastroscopy, and the infusion was stopped at the end of gastroscopy

Sponsors

West China Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

1. 18≤Age≤65 years old 2. American Society of Anaesthesiologists (ASA) Physical Status of I - II 3. 18≤BMI≤30 kg/m² 4. Outpatient patients who planned to undergo painless gastroscopy under propofol anesthesia

Exclusion criteria

1. Patients with communication disorders 2. Patients with alcohol and drug abuse or allergic or contraindicated drugs related to this trail 3. Patients who take anti-anxiety, depression or sedative drugs 4. Patients who participated in or were participating in other clinical trials within 3 months

Design outcomes

Primary

MeasureTime frameDescription
The primary outcome is the incidence of moderate to severe body movement during gastroscopyThe time during gastroscopy, an average of 15 minutesModerate to severe body movement is defined as the twisting of the patient's body due to the stimulation of the gastroscopy, making it difficult to proceed with the procedure without additional propofol.

Secondary

MeasureTime frameDescription
Endoscopist satisfaction scoresAt the end of the gastroscopyEndoscopist satisfaction scores to sedation during gastroscopy were obtained at the end of the procedure, using a 11-point Likert scale, with 0 indicating very dissatisfiedand 10 indicating very satisfied
The incidence of hypotensionThe time during gastroscopy, an average of 15 minutesThe hypotension is defined as the blood pressure\<90/60 mm Hg or 20% lower at baseline
The incidence of bradycardiaThe time during gastroscopy,an average of 15 minutesThe bradycardia is defined as HR \<50 beats/min
The time of gastroscopyThe time from gastroscope insertion to gastroscope withdraw, an average of 15 minutesThe total time of gastroscopy
The propofol consumption during gastroscopyFrom anesthetic induction to discontinuation of propofol infusion, an average of 15 minutesThe total propofol consumption during gastroscopy
The time to awakeThe time from the end of gastroscopy to the observer's assessment alert sedation equal to 5, up to 30 minutesThe time to awake is defined as from the end of gastroscopy to the observer's assessment alert sedation equal to 5
The incidence of hypoxemiaThe time during gastroscopy,an average of 15 minutesThe hypoxemia is defined as Spo2\< 90%

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026